Molecular Formula | C6H12N2O4Pt |
Molar Mass | 371.25 |
Melting Point | 228-230°C |
Water Solubility | Soluble in water. |
Solubility | Sparingly soluble in water, very slightly soluble in acetone and in ethanol (96 per cent). |
Appearance | White solid |
Color | white |
Merck | 14,1822 |
Storage Condition | 2-8°C |
Stability | Stable. Incompatible with strong oxidizing agents. |
Sensitive | Sensitive to light |
MDL | MFCD00070464 |
Physical and Chemical Properties | White flocculent loose powder, sponge-like lumps, odorless. Soluble in water. It is easy to decompose when exposed to light. Acute toxic LD50 mice (mg/kg):150 intraperitoneal injection and 140 intravenous injection. Acute toxicity LD50 rats (mg/kg):85 intravenous injection. |
Use | Is the second generation of platinum anticancer drugs, its activity and cisplatin, biochemical properties and activity spectrum is similar, but the side effects were significantly lower than Cisplatin |
Hazard Symbols | T - Toxic |
Risk Codes | R46 - May cause heritable genetic damage R61 - May cause harm to the unborn child R20/21/22 - Harmful by inhalation, in contact with skin and if swallowed. R42/43 - May cause sensitization by inhalation and skin contact. R20/21 - Harmful by inhalation and in contact with skin. |
Safety Description | S53 - Avoid exposure - obtain special instructions before use. S22 - Do not breathe dust. S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
UN IDs | 2811 |
WGK Germany | 3 |
RTECS | TP2300000 |
HS Code | 28439000 |
Toxicity | LD50 in mice (mg/kg): 150 i.p., 140 i.v.; in rats (mg/kg): 85 i.v. (Lelieveld) |
Raw Materials | Silver sulfate Barium hydroxide |
Reference Show more | 1. [IF=7.46] Ying Zhang et al."A polydopamine-polyethyleneimine/quantum dot sensor for instantaneous readout of cell surface charge to reflect cell states."Sensor Actuat B-Chem. 2020 Dec;324:128696 |
white powder or crystalline powder, odorless. Slightly soluble in water, insoluble in ethanol, acetone, chloroform or ether. Easily decomposed in light. When the temperature is higher than 120 ℃, the appearance gradually changes color, and the decomposition temperature is 247~258 ℃. Solid carboplatin is relatively stable to light, unstable in its aqueous solution, prone to degradation, degradation products of dihydramine platinum dihydrate, UV irradiation accelerates its degradation. Carboplatin and aluminum can produce black precipitation, should not be directly contacted.
potassium chloroplatinate is reacted with hydrazine hydrochloride and potassium iodide to obtain cisplatin iodide, which can be purified by recrystallization from a mixture of dimethylformamide and ethanol. Cisplatin cisplatin iodide was added into water, and Silver sulfate was slowly added dropwise. The reaction was completed. The insoluble matter was filtered off, and 1,1-ring barium butane dicarboxylate was slowly added to the filtrate, reacted at room temperature, allowed to stand, filtered, and the filtrate was evaporated to dryness. The resulting solid was washed with water and ethanol, respectively. After drying, carboplatin was obtained.
This product is cis -1,1-cyclobutane two diamino platinum acid. The content of C6H12N204Pt shall be between 98.0% and 102.0% calculated as the dry product.
developed by the U. S. Company Johnson-Matthy, launched in 1986. Second-generation platinum complex antineoplastic agents. The anti-tumor spectrum and anti-tumor activity were similar to cisplatin, but the water solubility was better than Cisplatin, and the toxicity to kidney was lower. Because of its strong anti-tumor activity, gastrointestinal reaction and low renal toxicity, it has been widely used. It can combine with DNA to form a cross bond, which destroys the function of DNA and makes it unable to replicate and synthesize. It is a non-specific drug of cell cycle. Mainly applicable to ovarian cancer, lung cancer, head and neck cancer, germ cell tumors, thyroid cancer, cervical cancer, bladder cancer, etc. Intravenous infusion should avoid direct sun exposure, it is best to use black paper to shield light, otherwise easy to decompose failure. Combined with other anticancer drugs, the curative effect is better.
mouse LDso (mg/kg): 150 intraperitoneal injection, 140 intravenous injection. Rat LD50(mg/kg): 85 intravenous injection.
take about 0.5g of this product, weigh it precisely, and burn it to constant weight at 0841 ° C according to the method of burning residue inspection (General Rule 400, but without sulfuric acid), the weight of the obtained residue was the weight of platinum contained in the Test amount. According to the dry product calculation, the molybdenum content of this product should be 52.0% ~ 53.0%.
take 80mg of this product, Add 10ml of water to dissolve, and then measure it according to law (General rule 0631). The pH value should be 5.5~7.5.
take 80mg of this product, add 10ml of water to dissolve, the solution should be clear.
take this product, add mobile phase to dissolve and dilute to make a solution containing lmg per lml as a test solution (ready to use new system); Take 2mg of 1, 1-cyclobutane dicarboxylic acid, in a 200ml measuring flask, 1 ml of the test solution was added precisely, diluted to the scale with the mobile phase, and shaken to serve as a control solution. According to the test of high performance liquid chromatography (General rule 0512), the silica gel bonded with eighteen alkyl silane was used as the filler, and tetrabutylammonium hydrogen sulfate buffer solution (8.5g tetrabutylammonium hydrogen sulfate, 80ml of water was added to dissolve, 3.4 of phosphoric acid was added, and the pH value was adjusted to 7.55 with 10 mol/L sodium hydroxide solution. The mobile phase was water-acetonitrile (20:880:100), the theoretical plate number calculated from the carboplatin peak is not less than 5000, the degree of separation between the 1, 1-cyclobutane dicarboxylic acid peak and the carboplatin peak should be greater than 2.5. Take 100 u1 of each of the test solution and the control solution respectively, inject the human liquid chromatograph, record the chromatogram to 4 times of the retention time of the main component peak. If there is a 1, 1-cyclobutane dicarboxylic acid peak in the chromatogram of the test solution, the peak area multiplied by 7.96 shall not be greater than the carboplatin Peak area of the test solution (0.5%).
take this product, add water to dissolve and dilute to make a solution containing about 1 mg per 1 ml, as a test solution; Take an appropriate amount of precision, A solution containing 10ug per 1 ml was prepared as a control solution by quantitative dilution with water. According to the chromatographic conditions under the content determination item, 10 u1 of the test solution and 10 u1 of the control solution are accurately measured and injected into the human liquid chromatograph respectively, and the chromatogram is recorded to 3 times of the retention time of the main component peak. If there are impurity peaks in the chromatogram of the test solution, the sum of each impurity peak area shall not be more than 2 times (2.0%) of the main peak area of the control solution.
take 80mg of this product, add 10ml of water to dissolve, add 2ml of dilute hydrochloric acid, boil for 5 minutes, add evaporated water, cool, filter with filter paper washed with hydrochloric acid solution (1-40), the residue and funnel are washed with a small amount of water (about 2ml), the washing liquid and the filtrate are combined, 0.5 of dilute sulfuric acid is added, and the mixture is left for 30 minutes without turbidity.
take this product, dry to constant weight at 105°C, weight loss shall not exceed 0.5% (General rule 0831).
measured by high performance liquid chromatography (General 0512).
silica gel bonded with eighteen alkyl silane was used as the filler; Water was used as the mobile phase; The detection wavelength was 229nm. The number of theoretical plates is not less than 3000 based on the carboplatin peak.
take an appropriate amount of this product, accurately weigh it, add water to dissolve and quantitatively dilute it to make a solution containing about 0.2mg per lml, as a sample solution, and inject 10ul into the liquid chromatograph with precise amount, the chromatogram was recorded; Another carboplatin reference substance was taken for determination by the same method. According to the external standard method to calculate the peak area, that is.
antineoplastic agents.
It was sealed and kept in a cool and dark place.
This product is a sterile aqueous solution of carboplatin containing carboplatin (C6H12N204Pt) between 90.0% and 105.0% of label load.
This product is colorless to yellowish clear liquid.
Same as Capper.